{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T16:03:34Z","timestamp":1721923414487},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,18]]},"DOI":"10.7759\/cureus.13434","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T07:42:20Z","timestamp":1613720540000},"source":"Crossref","is-referenced-by-count":0,"title":["An Unlikely Case of Benztropine Misuse in an Elderly Schizophrenic"],"prefix":"10.7759","author":[{"given":"Michael","family":"Esang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulziibat S","family":"Person","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odeyuwa O","family":"Izekor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thien Kim","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donya","family":"Ahmadian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.51.7.928","article-title":"Misuse of anticholinergic drugs by people with serious mental illness","volume":"51","author":"Buhrich N","year":"2000","unstructured":"Buhrich N, Weller A, Kevans P. Misuse of anticholinergic drugs by people with serious mental illness. Psychiatr Serv. 2000, 51:928-929. 10.1176\/appi.ps.51.7.928","journal-title":"Psychiatr Serv"},{"key":"ref2","article-title":"Mood elevation and medications","volume":"38","author":"Dugas JE","year":"1977","unstructured":"Dugas JE. Mood elevation and medications. Dis Nerv Syst. 1977, 38:958.","journal-title":"Dis Nerv Syst"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2006.01.017","article-title":"Comparative structure-activity relationships of benztropine analogues at the dopamine transporter and histamine H1 receptors","volume":"14","author":"Kulkarni SS","year":"2006","unstructured":"Kulkarni SS, Kopajtic TA, Katz JL, Newman AH. Comparative structure-activity relationships of benztropine analogues at the dopamine transporter and histamine H1 receptors. Bioorg Med Chem. 2006, 14:3625-3634. 10.1016\/j.bmc.2006.01.017","journal-title":"Bioorg Med Chem"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.123315","article-title":"Applicability of the dopamine and rate hypotheses in explaining the differences in behavioral pharmacology of the chloro-benztropine analogs: Studies conducted using intracerebral microdialysis and population pharmacodynamic modeling","volume":"322","author":"Othman AA","year":"2007","unstructured":"Othman AA, Newman AH, Eddington ND. Applicability of the dopamine and rate hypotheses in explaining the differences in behavioral pharmacology of the chloro-benztropine analogs: Studies conducted using intracerebral microdialysis and population pharmacodynamic modeling. J Pharmacol Exp Ther. 2007, 322:760-769. 10.1124\/jpet.107.123315","journal-title":"J Pharmacol Exp Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2011.08.039","article-title":"Urothelial\/lamina propria spontaneous activity and the role of M3 muscarinic receptors in mediating rate responses to stretch and carbachol","volume":"78","author":"Moro C","year":"2011","unstructured":"Moro C, Uchiyama J, Chess-Williams R. Urothelial\/lamina propria spontaneous activity and the role of M3 muscarinic receptors in mediating rate responses to stretch and carbachol. Urology. 2011, 78:P1442.E9-1442.E15. 10.1016\/j.urology.2011.08.039","journal-title":"Urology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181e7f2ab","article-title":"Use of anticholinergics and the risk of cognitive impairment in an African American population","volume":"75","author":"Campbell NL","year":"2010","unstructured":"Campbell NL, Boustani MA, Lane KA, et al.. Use of anticholinergics and the risk of cognitive impairment in an African American population. Neurology. 2010, 75:152-159. 10.1212\/WNL.0b013e3181e7f2ab","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.01309","article-title":"","volume":"13","author":"L\u00f3pez-\u00c1lvarez J","year":"2019","unstructured":"L\u00f3pez-\u00c1lvarez J, Sevilla-Llewellyn-Jones J, Ag\u00fcera-Ortiz L. Anticholinergic Drugs in Geriatric Psychopharmacology. Front Neurosci. 2019, 13:1309. 10.3389\/fnins.2019.01309","journal-title":"Anticholinergic Drugs in Geriatric Psychopharmacology. Front Neurosci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03660.x","article-title":"Haloperidol and benztropine interaction presenting as acute intestinal pseudo-obstruction","volume":"96","author":"Sheikh RA","year":"2001","unstructured":"Sheikh RA, Prindiville T, Yasmeen S. Haloperidol and benztropine interaction presenting as acute intestinal pseudo-obstruction. Am J Gastroenterol. 2001, 96:934-935. 10.1111\/j.1572-0241.2001.03660.x","journal-title":"Am J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.12088","article-title":"Benefits and limits of anticholinergic use in schizophrenia: focusing on its effect on cognitive function","volume":"68","author":"Ogino S","year":"2014","unstructured":"Ogino S, Miyamoto S, Miyake N, Yamaguchi N. Benefits and limits of anticholinergic use in schizophrenia: focusing on its effect on cognitive function. Psychiatry Clin Neurosci. 2014, 68:37-49. 10.1111\/pcn.12088","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4172\/2329-6488.1000263","article-title":"Anticholinergic use and misuse in psychiatry: a comprehensive and critical review","volume":"5","author":"Naja WJ","year":"2017","unstructured":"Naja WJ, Halaby A. Anticholinergic use and misuse in psychiatry: a comprehensive and critical review. J Alcohol Drug Depend. 2017, 5:263. 10.4172\/2329-6488.1000263","journal-title":"J Alcohol Drug Depend"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/jcp.0000000000000790","article-title":"The impact of medication anticholinergic burden on cognitive performance in people with schizophrenia","volume":"37","author":"Ang MS","year":"2017","unstructured":"Ang MS, Rashid NA, Lam M, et al.. The impact of medication anticholinergic burden on cognitive performance in people with schizophrenia. J Clin Psychopharmacol. 2017, 37:651-656. 10.1097\/jcp.0000000000000790","journal-title":"J Clin Psychopharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1017\/s0033291716002154","article-title":"Anticholinergic burden in schizophrenia and ability to benefit from psychosocial treatment programmes: A 3-year prospective cohort study","volume":"46","author":"O'reilly K","year":"2016","unstructured":"O'reilly K, O'connell P, Donohoe G, et al.. Anticholinergic burden in schizophrenia and ability to benefit from psychosocial treatment programmes: A 3-year prospective cohort study. Psychol Med. 2016, 46:3199-3211. 10.1017\/s0033291716002154","journal-title":"Psychol Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2017.03.034","article-title":"Cognitive burden of anticholinergic medications in psychotic disorders","volume":"190","author":"Eum S","year":"2017","unstructured":"Eum S, Hill SK, Rubin LH, et al.. Cognitive burden of anticholinergic medications in psychotic disorders. Schizophrenia Res. 2017, 190:129-135. 10.1016\/j.schres.2017.03.034","journal-title":"Schizophrenia Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/0706743719856846","article-title":"Book review: Stahl\u2019s essential psychopharmacology, prescriber\u2019s guide, antipsychotics","volume":"64","author":"Awad G","year":"2019","unstructured":"Awad G. Book review: Stahl\u2019s essential psychopharmacology, prescriber\u2019s guide, antipsychotics. Can J Psychiatry. 2019, 64:584. 10.1177\/0706743719856846","journal-title":"Can J Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/51438-an-unlikely-case-of-benztropine-misuse-in-an-elderly-schizophrenic","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:54Z","timestamp":1707507234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/51438-an-unlikely-case-of-benztropine-misuse-in-an-elderly-schizophrenic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,18]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.13434","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,18]]}}}